iOx Therapeutics Ltd.

About:

iOx Therapeutics Ltd. operates as an immuno-oncology company.

Top Investors: Portage Biotech, Horizon 2020

Description:

iOx Therapeutics Ltd. operates as an immuno-oncology company. Founded in February 2015 by Professor Cerundolo, iOx Therapeutics is a spin-out from the University of Oxford started to commercialize discoveries made as part of a long-running collaboration between Oxford and the Ludwig Institute for Cancer Research. iOx intends to develop and commercialize multiple synthetic lipid compounds discovered by a research team led by Professor Cerundolo.